InvestorsHub Logo
Followers 466
Posts 26934
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 95

Wednesday, 03/28/2012 11:27:29 AM

Wednesday, March 28, 2012 11:27:29 AM

Post# of 296
8:04AM Nektar Therapeutics confirmed that partner Affymax (AFFY) has announced FDA approval of OMONTYS (NKTR) 8.21 : Co reported that its partner Affymax announced that the FDA has approved OMONTYS Injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. Nektar and Affymax have an exclusive agreement under which Nektar provides Affymax with its proprietary PEGylation technology for use in OMONTYS. Under the terms of the agreement, Nektar is entitled to milestones, manufacturing revenues, and royalties on the global sales of OMONTYS.


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News